Nucleic acid molecule encoding the potassium channel protein, KCNQ5

US6617131B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Klaus Steinmeyer · Frankfurt am Main, DE
• Christian Lerche · Paris, FR
• Constanze Scherer · Tübingen, DE
• Guiscard Seebohm · Polle, DE
• Andreas Busch · Tirol, DE

Key dates

• Filing date: Mar 21, 2001
• Grant date: Sep 9, 2003
• Expiry date: Mar 21, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2799/021
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

KCNQ5, DNA encoding KCNQ5 or a polypeptide having KCNQ5 activity, related vectors, host cells and methods and a screening assay for identification of compounds which modify activity of a potassium channel KCNQ5 are described.